Aptose Biosciences (APS) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free APS Stock Alerts C$1.70 +0.08 (+4.94%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAptose Biosciences Inc. (APTO) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 28 at 5:43 PMAptose Biosciences's Earnings: A Previewbenzinga.com - March 25 at 1:49 PMAptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Optionfinance.yahoo.com - January 31 at 5:42 PMClosing Bell: Aptose Biosciences Inc flat on Wednesday (APS)theglobeandmail.com - December 20 at 8:06 PMAptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meetingfinance.yahoo.com - December 9 at 8:29 PMAptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Rolefinance.yahoo.com - November 30 at 5:41 PMAptose Biosciences Inc. (NASDAQ:APTO) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 10 at 12:53 PMAptose Reports Results for the Third Quarter 2023finance.yahoo.com - November 9 at 8:15 PMAptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meetingtheglobeandmail.com - November 2 at 12:30 PMAptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meetingfinance.yahoo.com - November 2 at 12:30 PMAptose Biosciences, Inc.: Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinibfinanznachrichten.de - October 30 at 1:16 PMAptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November 9, 2023finance.yahoo.com - October 26 at 8:12 AMPromising Prospects of Tuspetinib Drive Buy Rating for Aptose Biosciences: An Analyst’s Perspectivemarkets.businessinsider.com - October 20 at 8:50 AMClosing Bell: Aptose Biosciences Inc up on Friday (APS)theglobeandmail.com - October 7 at 8:23 AMClosing Bell: Aptose Biosciences Inc up on Thursday (APS)theglobeandmail.com - August 25 at 5:05 PMClosing Bell: Aptose Biosciences Inc flat on Monday (APS)theglobeandmail.com - August 22 at 9:24 AMAptose Biosciences, Inc.: Aptose Reports Results for the Second Quarter 2023finanznachrichten.de - August 11 at 6:19 AMAptose Reports Results for the Second Quarter 2023finance.yahoo.com - August 11 at 1:19 AMAptose Biosciences: Top 10 Undervalued Biotechnology Industry Stocks (APS)theglobeandmail.com - August 7 at 12:13 AMAptose Biosciences: Stocks Undervalued by Analyst Consensus on TSX (APS)theglobeandmail.com - July 21 at 11:31 PMAptose Biosciences, Inc.: Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliancefinanznachrichten.de - June 27 at 7:38 AMAptose Biosciences, Inc.: Aptose Biosciences Provides Update on Reverse Stock Splitfinanznachrichten.de - June 5 at 8:57 AMAptose to Hold Interim Clinical Update Webcast on Saturday, June 10, 2023finance.yahoo.com - May 31 at 8:04 AMAptose to sell up to $25M stock in the U.S.seekingalpha.com - May 26 at 7:57 AMClosing Bell: Aptose Biosciences Inc flat on Tuesday (APS)theglobeandmail.com - May 17 at 4:44 AMAptose Biosciences Inc.'s (TSE:APS) Path To Profitabilityfinance.yahoo.com - May 11 at 9:23 AMClosing Bell: Aptose Biosciences Inc down on Wednesday (APS)theglobeandmail.com - May 10 at 11:22 PMAptose Reports Results for the First Quarter 2023finance.yahoo.com - May 8 at 7:50 PMAptose to Participate in RBC Capital Markets 2023 Global Healthcare Conferencefinance.yahoo.com - May 4 at 7:29 AMClosing Bell: Aptose Biosciences Inc up on Monday (APS)theglobeandmail.com - May 2 at 1:51 PMAptose Biosciences to Participate in Cantor’s The Future of Oncology Virtual Symposiumfinance.yahoo.com - March 28 at 7:24 PMAptose Biosciences Inc. (NASDAQ:APTO) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 27 at 9:34 AMAptose Biosciences, Inc.: Aptose Reports Results for the Fourth Quarter and Full Year 2022finanznachrichten.de - March 25 at 12:13 AMAptose Reports Immaterial Financial Exposure to Silicon Valley Bankfinance.yahoo.com - March 10 at 10:42 PMAptose Biosciences to Present at Oppenheimer 33rd Annual Healthcare Conferencefinance.yahoo.com - March 2 at 8:29 AMWe Think Aptose Biosciences (TSE:APS) Needs To Drive Business Growth Carefullyfinance.yahoo.com - December 30 at 8:36 AMStocks in play: Aptose Biosciences Incca.finance.yahoo.com - December 12 at 4:04 PMSeagen (SGEN) Inks Deal With LAVA Therapeutics for LAVA-1223finance.yahoo.com - September 27 at 1:46 PMAptose Strengthens Board of Directors with Appointment of Bernd R. Seizinger, M.D., Ph.D.finance.yahoo.com - September 13 at 9:17 AMAptose's New "G3" Formulation of Luxeptinib Boosts Bioavailabilitybenzinga.com - September 12 at 10:12 AMIs Aptose Biosciences (TSE:APS) In A Good Position To Invest In Growth?finance.yahoo.com - July 23 at 9:49 AMAptose to Report Second Quarter 2022 Financial Results and Hold Conference Call on Tuesday, August 2, 2022finance.yahoo.com - July 19 at 6:01 PMAptose Biosciences Inc. to Post Q2 2022 Earnings of ($0.17) Per Share, Oppenheimer Forecasts (TSE:APS)marketbeat.com - May 14 at 2:36 AMAptose Reports Results for the First Quarter 2022finance.yahoo.com - May 9 at 6:02 PMAptose Receives Fast Track Designation for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutationfinance.yahoo.com - May 4 at 8:08 AMAptose to Report Fourth Quarter and Full Year 2021 Financial Results and Hold Conference Call on Tuesday, March 22, 2022finance.yahoo.com - March 8 at 8:35 AMAptose to Present at Oppenheimer’s 32nd Annual Healthcare Conferencefinance.yahoo.com - March 1 at 6:40 PMAptose Biosciences Climbs 17% to Reclaim Some Lossesmsn.com - December 16 at 2:29 PMInsiders who purchased this year lose US$89k as Aptose Biosciences Inc. (TSE:APS) stock drops to CA$1.44finance.yahoo.com - December 15 at 8:35 AMHM43239 Demonstrates Durable Clinical Benefit in Acute Myeloid Leukemiafinance.yahoo.com - December 13 at 7:04 PM Get Aptose Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details APS Media Mentions By Week APS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APS News Sentiment▼0.000.32▲Average Medical News Sentiment APS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APS Articles This Week▼00▲APS Articles Average Week Get Aptose Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: COV News Today CZO News Today KNE News Today REUN News Today IBT News Today SBM News Today RVX News Today ATE News Today IMV News Today AEZS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:APS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
